Cardiac Allograft Vasculopathy Medication Savings with TheDrugClub
Discount pricing may be available. Current formulary eligibility is being verified; a condition association does not establish FREE coverage.
- Join TheDrugClub as a member
- Receive your member card by email
- Present your card at a participating pharmacy
- Check active-formulary eligibility or available discount pricing
About Cardiac Allograft Vasculopathy
Cardiac Allograft Vasculopathy (CAV) is a serious complication affecting the arteries of a transplanted heart, often leading to heart failure. Managing CAV requires ongoing medication, which can be a significant financial burden. TheDrugClub helps ease this stress by providing substantial prescription savings, ensuring you can afford the vital treatments needed to protect your new heart.
Cardiac Allograft Vasculopathy (CAV) is a progressive form of coronary artery disease that affects people who have received a heart transplant. Unlike typical atherosclerosis, which often involves plaque buildup, CAV is a diffuse hardening and narrowing of the small arteries *within* the transplanted heart itself. It's a leading cause of long-term complications and mortality after a heart transplant. The immune system's ongoing response to the new organ, even with immunosuppressants, plays a key role in its development. Early detection is challenging as symptoms often don't appear until the disease is advanced.
Managing CAV primarily involves preventing its progression and treating its symptoms. Lifelong immunosuppressive medications are crucial not only to prevent rejection but also to slow CAV. Drugs
The information above is for educational purposes only and does not constitute medical advice. Consult your healthcare provider before making medication decisions.